Home
Theravance Inc

Theravance Inc Market Share Analysis for November 2025

View the board of directors for Theravance Biopharma.

Health > Biotechnology and Pharmaceuticals

Domaintheravance.com

Year Founded1996

Employees51 - 200

Annual Revenue$50M - $75M

Theravance Inc

Theravance Inc (including company regionals)

theravance.com

See more website traffic and engagement information

Theravance Inc Revenue up to November 2025 is 50M - 75M

revenue generated by Theravance Inc top domains

Theravance Inc top domains revenue over 3 years

Revenue for Theravance Inc top domains

theravance.com50M - 75M

See more with Sales Intelligence

Total visits to Theravance Inc's top domains

Understand Theravance Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

theravance.com5.4K

See more with Sales Intelligence

Avg. visit duration in Theravance Inc's top domains

Analyze Theravance Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

theravance.com00:00:32

See more with Sales Intelligence

Avg. pageviews on Theravance Inc's top domains

See how Theravance Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

theravance.com1.54

See more with Sales Intelligence

Theravance Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

medivation.comCompany NameMedivationEmployees501 - 1000HQUnited States, California, San FranciscoAnnual revenue$500M - $1BTotal visits--Health > Biotechnology and Pharmaceuticals

Top technologies used by Theravance Inc

These are the website technologies, by industry, used by Theravance Inc top domains

Widget (5)

Twemoji

Marketing (3)

Google Marketing Platform

Content Management System (2)

WordPress

Conversion & Analytics (2)

Google Analytics

More Technologies

9

See all

News & Signals from Theravance Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTheravance Biopharma US, Inc. attends event 2025 CHEST Annual Meeting.Theravance Biopharma to present new analyses highlighting YUPELRI(R)(revefenacin) outcomes in COPD at the 2025 CHEST Annual Meeting.

NewsTheravance Biopharma US, Inc. attends event BTIG Virtual Biotechnology Conference.Theravance Biopharma (NASDAQ: TBPH) announced its participation in the upcoming BTIG Virtual Biotechnology Conference.

NewsTheravance Biopharma US, Inc. attended event H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 13th '25.DUBLIN, May 13, 2025 /PRNewswire/ - Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York City at NASDAQ Tuesday, May 20 at 10:30 AM EDT (7:30 AM PDT / 3:30 PM IST) and will be hosting in-person meetings with the investment community at the conference.